  | ANGELI, C., PHILIPPIDOU, D., KLEIN, E., WURTH-MARGUE, C., GHOSH, S., Maldonado, M. L. C., Tiso, N., Risato, G., Irfan, F., Santos, B., Cutrona, M., Wroblewska, J. P., & KREIS, S. (01 October 2025). High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma. Journal of Experimental and Clinical Cancer Research, 44 (1), 278. doi:10.1186/s13046-025-03539-9  Peer reviewed |
 | ANGELI, C. (2025). High-Throughput Drug Discovery for NRAS-Mutant Melanoma: Leveraging Advanced Preclinical Co-Culture Models [Doctoral thesis, Cristian Angeli]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/64672 |
KREIS, S., ANGELI, C., WROBLEWSKA, J. P., PHILIPPIDOU, D., KLEIN, E., WURTH-MARGUE, C., & GHOSH, S. (2025). High-throughput screening of advanced multicomponent pre-clinical 3D melanoma models identifies potential first-line targeted therapies for NRAS mutant melanoma. EJC Skin Cancer, 3, 100486. doi:10.1016/j.ejcskn.2025.100486 |
ANGELI, C., WROBLEWSKA, J. P., KLEIN, E., WURTH-MARGUE, C., PHILIPPIDOU, D., & KREIS, S. (2025). Innovative 3D multicomponent melanoma models for in vitro drug screening. EJC Skin Cancer, 3, 100485. doi:10.1016/j.ejcskn.2025.100485 |
 | GUREGHIAN, V., HERBST, H., KOZAR, I., MIHAJLOVIC, K., Malod-Dognin, N., Ceddia, G., ANGELI, C., WURTH-MARGUE, C., RANDIC, T., PHILIPPIDOU, D., TETSI NOMIGNI, M., HEMEDAN, A., TRANCHEVENT, L.-C., LONGWORTH, J., Bauer, M., BADKAS, A., GAIGNEAUX, A., Muller, A., OSTASZEWSKI, M., ... KREIS, S. (October 2023). A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma. Cancer Gene Therapy, 30 (10), 1330 - 1345. doi:10.1038/s41417-023-00640-z Peer Reviewed verified by ORBi |